In Belgium, the main increases over the 15-year period are observed in the chronic myeloid malignancies, particularly the three main subtypes of BCR::ABL1-negative MPN (PV, ET, and PMF, which exhibit a similar AAPC of around 6%), followed by MDS and MDS/MPN. Here, ABL1 is linked to essential thrombocythemia.